Lyell has prioritized its pipeline to focus on next-generation CAR T-cell therapies, including IMPT-314 and LYL119, and is discontinuing development of LYL797, LYL845 and earlier-stage TIL programs ...
I thought of something new because I'm writing many stories about diecast cars. I'll soon start discussing scale-model motorcycles ... I don't even care that it sports the same look as in the 2022 ...
Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures ...